Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of BRL 799.82 billion. The enterprise value is 1.09 trillion.

Market Cap	799.82B
Enterprise Value	1.09T

Important Dates

The last earnings date was Tuesday, February 3, 2026.

Earnings Date	Feb 3, 2026
Ex-Dividend Date	Jan 22, 2026

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-0.49%
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	66.53%
Float	5.68B

Valuation Ratios

The trailing PE ratio is 18.69 and the forward PE ratio is 8.93.

PE Ratio	18.69
Forward PE	8.93
PS Ratio	2.32
PB Ratio	1.67
P/TBV Ratio	n/a
P/FCF Ratio	16.00
P/OCF Ratio	12.41
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.71, with an EV/FCF ratio of 21.76.

EV / Earnings	25.41
EV / Sales	3.28
EV / EBITDA	7.71
EV / EBIT	10.72
EV / FCF	21.76

Financial Position

The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.78.

Current Ratio	1.16
Quick Ratio	0.80
Debt / Equity	0.78
Debt / EBITDA	2.54
Debt / FCF	7.45
Interest Coverage	7.17

Financial Efficiency

Return on equity (ROE) is 8.89% and return on invested capital (ROIC) is 13.65%.

Return on Equity (ROE)	8.89%
Return on Assets (ROA)	5.68%
Return on Invested Capital (ROIC)	13.65%
Return on Capital Employed (ROCE)	11.20%
Weighted Average Cost of Capital (WACC)	5.55%
Revenue Per Employee	4.60M
Profits Per Employee	570,702
Employee Count	81,000
Asset Turnover	0.30
Inventory Turnover	1.41

Taxes

Income Tax	-1.47B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -9.56% in the last 52 weeks. The beta is 0.44, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.44
52-Week Price Change	-9.56%
50-Day Moving Average	34.65
200-Day Moving Average	33.86
Relative Strength Index (RSI)	50.96
Average Volume (20 Days)	9,050

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	3.08

Income Statement

In the last 12 months, Pfizer had revenue of BRL 344.69 billion and earned 42.80 billion in profits. Earnings per share was 7.51.

Revenue	344.69B
Gross Profit	261.29B
Operating Income	105.56B
Pretax Income	41.43B
Net Income	42.80B
EBITDA	141.65B
EBIT	105.56B
Earnings Per Share (EPS)	7.51

Full Income Statement

Balance Sheet

The company has 74.89 billion in cash and 372.60 billion in debt, giving a net cash position of -297.71 billion.

Cash & Cash Equivalents	74.89B
Total Debt	372.60B
Net Cash	-297.71B
Net Cash Per Share	n/a
Equity (Book Value)	477.96B
Book Value Per Share	83.77
Working Capital	32.57B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 64.47 billion and capital expenditures -14.48 billion, giving a free cash flow of 49.99 billion.

Operating Cash Flow	64.47B
Capital Expenditures	-14.48B
Free Cash Flow	49.99B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 75.81%, with operating and profit margins of 30.62% and 12.42%.

Gross Margin	75.81%
Operating Margin	30.62%
Pretax Margin	12.02%
Profit Margin	12.42%
EBITDA Margin	41.10%
EBIT Margin	30.62%
FCF Margin	14.50%

Dividends & Yields

This stock pays an annual dividend of 1.58, which amounts to a dividend yield of 4.51%.

Dividend Per Share	1.58
Dividend Yield	4.51%
Dividend Growth (YoY)	-3.58%
Years of Dividend Growth	2
Payout Ratio	125.74%
Buyback Yield	-0.23%
Shareholder Yield	4.28%
Earnings Yield	5.35%
FCF Yield	6.25%

Dividend Details

Stock Splits

The last stock split was on October 29, 2020. It was a forward split with a ratio of 4.

Last Split Date	Oct 29, 2020
Split Type	Forward
Split Ratio	4

Scores

Pfizer has an Altman Z-Score of 2.11 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.11
Piotroski F-Score	6